EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study

Melaku Yalew iD, Anwar Mulugeta iD, Amanda L Lumsden iD, Iqbal Madakkatel iD, S Hong Lee iD, Martin K Oehler, Johanna Mäenpää, Elina Hyppönen iD

Nutrients · 2024

DOI: 10.3390/nu16213680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Melaku Yalew und 7 weiteren Autor:innen. Beteiligte Einrichtung: Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Vitamin K 1, Polymorphism, Single Nucleotide. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Future Fund of Australia, University of South Australia’s Enterprise Research Scholarship, National Health and Medical Research Council (NHMRC) Leadership Investigator Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Observational studies have linked vitamin K and cancer, but the causality of this association remains unknown. This Mendelian randomization (MR) study aims to investigate the association between circulating phylloquinone (vitamin K1) levels and four female-specific cancers.

Methods

We used four single-nucleotide polymorphisms (SNPs) to instrument phylloquinone, with the reported F-statistic 16.00–28.44 for all variants. SNP–outcome associations were obtained from consortia meta-analyses, UK Biobank, and the FinnGen database (up to 145,257/419,675, 27,446/362,324, 15,181/591,477, and 2211/320,454 cases/controls for breast, ovarian, endometrial, and cervical cancer, respectively). Analyses were conducted using five complementary MR methods including pleiotropy robust approaches. The MR Egger intercept test, MR PRESSO global test and leave-one-out analyses were used to test for and identify pleiotropic variants.

Results

The relevance of the instrument was validated by positive control analyses on coagulation factor IX (p = 0.01). However, the main MR analysis and all sensitivity analyses were consistently supportive of a null association between phylloquinone and all four cancers (p > 0.05 for all analyses, across all methods). MR-PRESSO did not detect outlying variants, and there was no evidence of horizontal pleiotropy relating to any cancer outcome (pintercept > 0.26 for all).

Conclusions

We found no evidence for an association between genetically predicted circulating phylloquinone levels and the risk of four female-specific cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mendelian Randomization AnalysisVitamin K 1Polymorphism, Single NucleotideHumansFemaleBreast NeoplasmsRisk FactorsOvarian NeoplasmsEndometrial NeoplasmsGenetic Predisposition to Disease

Stichwörter der Autor:innen

Mendelian randomizationcirculating phylloquinonefemale-specific cancersvitamin K1

Substanzen

Vitamin K 1

Autor:innen und Institutionen

  • Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, SA 5001, Australia.
  • South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.
  • Department of Public Health, College of Medicine and Health Sciences, Injibara University, Injibara P.O. Box 6040, Ethiopia.
  • Department of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia.
  • UniSA Allied Health & Human Performance, University of South Australia, Adelaide, SA 5001, Australia.
  • Department of Gynecological Oncology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.

ORCID-Profile: Melaku Yalew, Anwar Mulugeta, Amanda L Lumsden, Iqbal Madakkatel, S Hong Lee, Elina Hyppönen

Förderung

  • Medical Research Future Fund of Australia
  • University of South Australia’s Enterprise Research Scholarship
  • National Health and Medical Research Council (NHMRC) Leadership Investigator Award

Zitieren

APA

Yalew, M., Mulugeta, A., Lumsden, A. L., Madakkatel, I., Lee, S. H., Oehler, M. K., Mäenpää, J., & Hyppönen, E. (2024). Circulating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study. Nutrients. https://doi.org/10.3390/nu16213680

Vancouver

Yalew M, Mulugeta A, Lumsden AL, Madakkatel I, Lee SH, Oehler MK, et al. Circulating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study. Nutrients. 2024. doi:10.3390/nu16213680

BibTeX
@article{Yalew2024,
  author = {Yalew, Melaku and Mulugeta, Anwar and Lumsden, Amanda L and Madakkatel, Iqbal and Lee, S Hong and Oehler, Martin K and Mäenpää, Johanna and Hyppönen, Elina},
  title = {Circulating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16213680}
}
Kostenlos starten →